Latest Press Releases
AMCP In the News
This year marks Susan Cantrell’s 10th year as CEO of the Academy of Managed Care Pharmacy (AMCP).
Ahead of AMCP Nexus 2026, taking place October 26 to 29 in San Diego, California, she reflected on her decade with the organization, discussing how managed care pharmacy has evolved and how those changes are reflected in this year's program.
Watch more of Cantrell’s interview with The American Journal of Managed Care® here.
This year marks Susan Cantrell's 10th year as CEO of AMCP. Ahead of #AMCPNexus 2026 taking place October 26 to 29 in San Diego, California, she reflected on her decade with the organization, discussing how managed care pharmacy has evolved and how those changes are reflected in this year's program.
Watch more of Cantrell’s interview here.
Pharmacists are underutilized in the primary care realm, said Susan Cantrell, CEO of the Academy of Managed Care Pharmacy. “We’re at a point where we have access issues in primary care,” she said. “How do we make sure we are optimizing drug therapy and taking care of patients? And how do we compensate pharmacists for the work they do?”
Mitzi Wasik, PharmD, MBA, BCPS, the senior vice president for practice advancement and member experience at AMCP, underscored some potential benefits of AI in core managed care areas such as medication adherence.
In the latest episode of Worth a Shot, Adam Colborn, JD, AMCP VP of government affairs, warns that ongoing disruption to the Advisory Committee on Immunization Practices (ACIP) process threatens vaccine access, particularly for low-income children and other vulnerable populations.
The bipartisan Main Street Pharmacy Access Act (H.R. 3164/S. 2426), which would allow Medicare to reimburse pharmacists for testing and treating certain respiratory illnesses in states that already authorize those services, cleared the House Committee on Ways and Means on May 21.
Weight loss drugs will be available to adults 65 and older in Medicare for the first time next month, thanks to a government program that’s supposed to be temporary. It may be difficult to end it.
The bipartisan Main Street Pharmacy Access Act (H.R. 3164/S. 2426), which would allow Medicare to reimburse pharmacists for testing and treating certain respiratory illnesses in states that already authorize those services, cleared the House Committee on Ways and Means on May 21, 2026.